Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 03, 2021

SELL
$6.81 - $9.23 $368,972 - $500,090
-54,181 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$7.99 - $15.0 $117,764 - $221,085
14,739 Added 37.37%
54,181 $450,000
Q4 2020

Feb 12, 2021

BUY
$7.04 - $11.7 $101,009 - $167,871
14,348 Added 57.18%
39,442 $288,000
Q2 2020

Aug 14, 2020

BUY
$7.49 - $15.16 $45,119 - $91,323
6,024 Added 31.59%
25,094 $380,000
Q1 2019

May 15, 2019

BUY
$11.76 - $22.15 $105,840 - $199,350
9,000 Added 89.37%
19,070 $401,000
Q4 2018

Feb 13, 2019

BUY
$10.42 - $21.94 $22,507 - $47,390
2,160 Added 27.31%
10,070 $116,000
Q3 2018

Nov 14, 2018

BUY
$20.4 - $24.6 $66,096 - $79,704
3,240 Added 69.38%
7,910 $182,000
Q2 2018

Aug 14, 2018

BUY
$19.02 - $24.95 $16,167 - $21,207
850 Added 22.25%
4,670 $104,000
Q1 2018

May 14, 2018

BUY
$22.55 - $29.9 $12,402 - $16,445
550 Added 16.82%
3,820 $87,000
Q4 2017

Feb 14, 2018

BUY
$18.0 - $30.0 $58,860 - $98,100
3,270
3,270 $86,000

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $191M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Asset Management One Co., Ltd. Portfolio

Follow Asset Management One Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Asset Management One Co., Ltd. with notifications on news.